AI assistant
REVVITY, INC. — Director's Dealing 2022
Dec 23, 2022
30616_dirs_2022-12-23_a6d78605-092f-4175-bfb8-5ff911dc9ff1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PERKINELMER INC (PKI)
CIK: 0000031791
Period of Report: 2022-12-21
Reporting Person: Vohra Tajinder S (Please See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-21 | Common Stock | M | 1662 | $48.975 | Acquired | 18867 | Direct |
| 2022-12-21 | Common Stock | S | 362 | $140.567 | Disposed | 18505 | Direct |
| 2022-12-21 | Common Stock | S | 712 | $142.50 | Disposed | 17793 | Direct |
| 2022-12-21 | Common Stock | S | 588 | $143.466 | Disposed | 17205 | Direct |
| 2022-12-22 | Common Stock | M | 1663 | $48.975 | Acquired | 18868 | Direct |
| 2022-12-22 | Common Stock | S | 580 | $139.206 | Disposed | 18288 | Direct |
| 2022-12-22 | Common Stock | S | 673 | $140.372 | Disposed | 17615 | Direct |
| 2022-12-22 | Common Stock | S | 410 | $141.124 | Disposed | 17205 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-12-21 | NQ Stock Option (right to buy) | $48.975 | M | 1662 | Disposed | 2023-03-04 | Common Stock (1662) | Direct |
| 2022-12-22 | NQ Stock Option (right to buy) | $48.975 | M | 1663 | Disposed | 2023-03-04 | Common Stock (1663) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Vohra on November 16, 2022.
F2: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $140.25 to $140.74. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F3: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $142.13 to $143.09. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F4: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $143.25 to $143.66. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F5: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $138.85 to $139.72. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F6: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $139.95 to $140.75. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F7: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $140.95 to $141.36. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F8: This option became exercisable in three equal annual installments beginning on March 4, 2017, which was the first anniversary of the date on which the option was granted.